Hangzhou, China · Founded 2021 · Privately Held (backing)
Developer of furans bio-based materials designed to reduce carbon emissions. GS Biotech is based in Hangzhou, China and was founded in 2021. Its last reported valuation was $417 million in Feb 2025. It has raised $56.2 million.
Last reported valuation
$417.3M
Oct 2026
Priced at
—
Total raised
$56.2M
Last round
—
How much has GS Biotech raised?
$56.2Macross 0 recorded rounds
Free account
More of GS Biotech with a free account
·The complete investor list: 15 names
·Watch GS Biotech: the Monday email on marks, rounds and moves